Literature DB >> 12974941

Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.

Maria E Sobaniec-Lotowska1.   

Abstract

The aim of the study was to analyse the astrocyte ultrastructure within the hippocampal gyre cortex and neocortex of the temporal lobe in valproate encephalopathy induced by chronic administration of an anti-epileptic drug - sodium valproate (VPA) to rats for 1, 3, 6, 9 and 12 months, once daily intragastrically, in a dose of 200 mg/kg b.w. and after its withdrawal for 1 and 3 months. Prolonged application of VPA caused damage to protoplasmic astrocytes of the cortex regions examined, mainly in the pyramidal layer, which intensified in the later stages of the experiment, especially after 9 and 12 months. Ultrastructural alterations in astroglia during this experiment did not differ significantly between the hippocampal cortex and neocortex. The most pronounced astroglial abnormalities, concerning about 2/3 of protoplasmic astrocytes after 9 and 12 months, were characterized by considerable swelling of cells, with the presence of empty vacuolar structures in the cytoplasm, a substantial decrease in the number of gliofilaments or even their complete loss, which indicated fibrillopoietic failure of the cell, and the appearance of astrocytes showing phagocytic activity. The astrocytic changes coexisted with distinct damage to neurones and structural elements of the blood-brain barrier. One month after termination of chronic exposure to the drug, the abnormalities did not subside, whereas after 3 months features of distinct normalization could be observed in a considerable number, more than a half, of astrocytes. In valproate encephalopathy, apart from any direct effect of VPA and/or its metabolites on astrocytes, the main cause of the protoplasmic astroglial damage in the cortex of the CNS structures examined could be associated with changes in microcirculation in the cortex (vasogenic factor), leading to its ischaemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974941      PMCID: PMC2517555          DOI: 10.1046/j.1365-2613.2003.00343.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

1.  Valproate encephalopathy and hyperammonaemia.

Authors:  M O'Neill; R W Dubrey; R M Grocott-Mason
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

2.  Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.

Authors:  David G Vossler; Alan J Wilensky; David F Cawthon; Diana L Abson Kraemer; Linda M Ojemann; Lisa M Caylor; John D Morgan
Journal:  Epilepsia       Date:  2002-02       Impact factor: 5.864

3.  Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate.

Authors:  M E Sobaniec-Lotowska
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

Review 4.  The new generation of GABA enhancers. Potential in the treatment of epilepsy.

Authors:  S J Czuczwar; P N Patsalos
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Valproate-induced encephalopathy.

Authors:  W T Chen; D J Yen; H Y Yu; K K Liao
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  2001-08

6.  Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis.

Authors:  Y Ueda; L J Willmore
Journal:  Exp Brain Res       Date:  2000-08       Impact factor: 1.972

7.  Absence seizures aggravated by valproic acid.

Authors:  T Lerman-Sagie; N Watemberg; U Kramer; E Shahar; P Lerman
Journal:  Epilepsia       Date:  2001-07       Impact factor: 5.864

8.  [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].

Authors:  K G Rottach; J Weiss-Brummer; U Wieland; M Schmauss
Journal:  Nervenarzt       Date:  2000-05       Impact factor: 1.214

9.  Morphometric analysis of the cerebellar cortex capillaries in the course of experimental valproate encephalopathy and after chronic exposure to sodium valproate using transmission electron microscopy.

Authors:  M Sobaniec-Lotowska; W Sobaniec; A Augustynowicz
Journal:  Folia Neuropathol       Date:  2001       Impact factor: 2.038

10.  Ultrastructural features of the astrocytes involved in the phagocytic response to excitotoxins and anoxia in vitro.

Authors:  E Matyja
Journal:  Folia Neuropathol       Date:  1999       Impact factor: 2.038

View more
  3 in total

1.  A transmission electron microscopic study of microglia/macrophages in the hippocampal cortex and neocortex following chronic exposure to valproate.

Authors:  Maria E Sobaniec-Lotowska
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

2.  Sustained expression of osteopontin is closely associated with calcium deposits in the rat hippocampus after transient forebrain ischemia.

Authors:  Jang-Mi Park; Yoo-Jin Shin; Hong Lim Kim; Jeong Min Cho; Mun-Yong Lee
Journal:  J Histochem Cytochem       Date:  2012-04-11       Impact factor: 2.479

3.  Altered cortical thickness following prenatal sodium valproate exposure.

Authors:  Amanda G Wood; Jian Chen; Sarah Barton; Caroline Nadebaum; Vicki A Anderson; Cathy Catroppa; David C Reutens; Terence J O'Brien; Frank Vajda
Journal:  Ann Clin Transl Neurol       Date:  2014-07-03       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.